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ABSTRACT
Cellular membranes are important targets for many membrane-active peptides and
drug compounds. Here we are interested in deciphering how lipid membranes are perturbed by
several membrane-active molecules, including the transmembrane domain of the influenza M2
protein (M2TM), aggregates formed by a synthetic polyglutamine peptide, and three
polyphenol compounds (i.e., tamoxifen, genistein, and verapamil). We employ phase-separated
ternary lipid model membranes in the form of giant unilamellar vesicles (GUVs) to simulate raftlike structures that have been proposed to govern many important processes in plasma
membranes (e.g., intracellular singling and trafficking). Specifically, we use fluorescent
microscopy to interrogate how those membrane additives modulate the phase behavior of
free-standing GUVs, as well as the miscibility transition temperature (Tm). We find that M2TM
increases Tm and causes vesicle budding; polyglutamine aggregates disrupt lipid membranes;
and the three polyphenol compounds exert disparate effects on GUV Tm.
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CHAPTER ONE:
INTRODUCTION

1.1: Historical development of cell membrane theory and model
In ancient kingdoms, walls bordering the entire kingdom are vital to its survivability. The
defensive walls act as a separation between the chaos outside and the order inside, as well as
screening what passes through those walls via gates. Not only that, some kingdoms even had
inner walls that separate the royalty from the lower class social strata. Ingenuity of humans in
history to create kingdoms with walls has long been designed by nature. Humans within
themselves carries analogous blueprint for kingdom formation known as cells. Cell membranes
are akin to walls surrounding kingdoms.

Since the invention of microscope by Zacharias Janssen, cell membrane theory made its debut
through observation of plant’s cell wall by Anthony Leeuwenhoek in the 17th century. It took
about two centuries later for scientists like Moritz Traube and Heinrich Quincke to formulate
cell theory for animal cells. In short, Quincke postulated that cell membranes are made of a
layer of fat that is semipermeable [1]. Semipermeable membranes allow the passing of solvent
but not solute molecules. A century later, Hugo Fricke added to this understanding by
measuring cell membrane thickness to be 3.3 nm [2]. He mistakenly interpreted cell thickness
data to be composed of only a single molecular lipid layer. Fast forward a decade later, the first
1

lipid bilayer model came about from Gorter and Grendel, though it was an inaccurate model
[3]. They attributed membrane permeability to electrostatic repulsion rather than to
hydrophobic tendency found in the core of the membrane. Finally in 1950s, J. David Robertson
with the help of powerful electron microscopy interpreted cell membranes to be of bilayer
nature with hydrophilic headgroups [4].

Going back to late 19th century to early 1970s, a train of distinguished scientists such as
Wilhelm Pfeffer, Ernest Overton, Leonor Michaelis, Seymour Singer and Garth Nicolson to name
a few, helped in constructing what we now have as the fluid mosaic model of cell membranes.
This model shows embedded protein structure within the heterogeneous lipid bilayer
membranes (Figure 1).

Figure 1: Fluid Mosaic Model of cell membranes developed by Singer and Nicolson in 1972. The
model shows opposing headgroups away from the hydrophobic center. There are also proteins
embedded partially/fully within the membrane. These proteins are free to move around its
surrounding liquid bilayer. Image source:
https://commons.wikimedia.org/wiki/File%3ACell_membrane_detailed_diagram_en.svg
2

1.2: Outline of the thesis
This thesis work focuses on the interaction study between various peptide/polyphenol
molecules with lipid membranes in the form of giant unilamellar vesicles (GUVs). Specifically,
addition of peptides or polyphenol molecules alters intrinsic properties of lipid membranes
such as miscibility transition temperature (Tm) and membrane curvature. There are four major
parts that make up this masters thesis. First, GUVs of various lipid compositions were
concocted to study how lipid compositions modulate GUV phase separation. Cell membranes
contain raft-like structures that are more rigid compare to its “lax” surrounding. In model
membranes, liquid-ordered (Lo) phase is analogous to lipid rafts while liquid-disordered (Ld)
phase is analogous to the “lax” surrounding [5]. GUVs with Lo and Ld phase separation have
been suggested as reasonable models to represent heterogeneous organiziton in cell plasma
membranes. Part two covers the transmembrane domain of influenza M2 protein (M2TM)
addition to GUVs. Part three discusses the consequences of adding aggregates formed by a
syntemtic polyglutamine (polyQ) peptide to GUVs. This work conlcudes with studying the effect
of polyphenol molecules on the miscibility transition temperatire Tm of ternary GUVs. (Tm
studies were also performed for pure GUVs and M2TM-premixed GUVs.) In Tm study,
temperature was monitored when phase coexisting GUVs become homogeneous. Fluroescent
images of dye-doped GUVs were taken to observe membrane deformation.

3

1.3: Important instruments
Optical microscope was heavily utilized in this work. To show phase separation in Lo-Ld
phase coexisting GUVs, two modes of microscope imaging were used, i.e., bright field and
epifluorescence. In both modes, Lo phase corresponds to the dark region on GUVs and the Ld
phase corresponds to the bright region (i.e., the dye molecules used preferentially partition into
the disordered Ld phase). GUVs with ~30 µm diameter were used. GUVs were produced from
lipid mixtures using the electroformation process described by Angelova [6]. A temperature
probe (Type T) was placed inside an isolated custom-built copper chamber to measure GUV
miscibility transition temperature Tm. For comparison, atomic force microscopy data were also
presented.

1.4: Reasons of the studies
There are many reasons why the studies in this thesis are useful. The influenza A virus
for example depends on M2 peptide for virus invasion, replication and egress. It is known that
the endosomal sorting complex required for transport (ESCRT) is not responsible for influenza A
virus budding and scission. Hence a better understanding on how M2 peptide hijacks host cell
membranes is crucial [7]. It is also important to better understand how polyQ aggregates
disrupt lipid membranes. Pathogenic expansion of the CAG repeat in the gene encoding
huntingtin (htt) protein leads to the formation of polyQ mediated aggregates that are probably
responsible for the progressive neuronal Huntington’s disease (HD) in humans [8]. Polyphenol
molecules like tamoxifen and genistein are similar to each other functionally when it comes to
prevention of breast cancer. Tamoxifen has been widely used as an anticancer drug because of
4

its ability to compete with endogenous estrogen-receptor binding sites [9]. Verapamil is a
calcium channel blocker that treats hypertension, angina, and cardiac dysrhythmia. Thus
studies of these polyphenol molecules will enlighten us on molecular interactions with lipid
membranes so that we could improve on current available drugs.

5

CHAPTER TWO:
INSTRUMENTATIONS AND METHODOLOGY

2.1: Introduction
This thesis work began around August of 2014 in trying to study phase separation of
ternary GUVs. A year into working in the lab, Dr. Pan came to acquire a state of the art atomic
force microscopy (AFM). This instrument will be introduced briefly at the end of this chapter as
many of AFM works has been complimentary to this thesis work. This chapter will discuss
instrumentations such as the light microscopy and electroformation method, central to this
work.

2.2: Electroformation methods and instrumentation
This section will cover lipids used and instrumentation for GUV synthesis. The process
for synthesizing GUVs is called electroformation. In this process, two electrodes with deposited
lipids are surrounded in aqueous solution. The electrodes will be attached to a function
generator to generate AC voltage. This alternating voltage will excite both electrodes at a
certain frequency, causing the lipids deposited on the electrodes to swell and aggregate
according to hydrophobicity. All of the chemicals, lipids, and drug molecules are purchased
from Avanti Polar Lipids, Sigma Aldrich, and Fisher Scientific. PolyQ peptide (KK-Q35-KK) and
M2TM peptide (residues 22-46 of M2 protein, SSDPLVVAASIMGILHLILWILDRL) were either
6

synthesized by our collaborator, Dr. Jianfeng Cai’s group in the Department of Chemistry (USF),
or by the Peptide Synthesis Center at USF (http://chemistry.usf.edu/research/peptide/ ). The
two peptides are both prepared by solid phase synthesis method, HPLC purification, and
lyophilization. Lipids, including 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1, 2dioleoyl-sn-glycero-3-phosphocholine (DOPC), egg-sphingomyelin (ESM), cholesterol (Chol), and
the dye molecule 1, 2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (rhodamine-DPPE) were
prepared in chloroform or chloroform/methanol 3:1 v/v as stock solutions and stored at -80ᵒC.
Similarly, stock solutions of M2TM, tamoxifen, genistein, and verapamil are prepared and
stored at -80ᵒC. For polyQ, aggregates are formed by dissolving the peptide in 10 mM HEPES pH
7.4 buffer and stored at 4oC.

2.2.1: Lipids
Ternary mixtures of DOPC, ESM, and cholesterol were used in preparing GUVs through
electroformation method described by Angelova et al [6]. 0.2mol% rhodamine-DPPE dye was
added to lipid mixtures for fluorescence imaging. Electroformation is performed at high
temperature (60oC). GUVs prepared have lipid ratios ranging from 1:1 to 3:1 (DOPC:SM
mol/mol) with 0-50 mol% Chol. (All lipid mixtures were prepared in mole ratio, fraction, or
percentage.) Within this lipid ratio region, vesicles have been shown to contain both L o and Ld
phases as well as exhibiting interesting critical-like fluctuations when temperature is elevated
[10].

7

2.2.2: Pre-Electroformation
Proper amounts of lipid stock solutions were mixed into a 10ml glass test tube. This
mixture was sonicated and vortex briefly to ensure lipid homogeneity. Instead of electrode,
Indium-Tin-Oxide (ITO) glass slides were used as conductor. ITO slides are only coated on one
side. The homogenous lipid mixture was smeared onto heated ITO slides (~60 oC) and vacuumed
for 1 hour to remove any excess organic solvents. ITO slides were sandwiched with O-rings like
in Figure 2. The aqueous solution used here was 100 mM sucrose and 10 mM HEPES @ pH7.0.
Figure 3 shows instruments used.

Figure 2: Electroformation setup using ITO-glass slides, O-rings, and AC power supply. (a)
Ternary lipid mixture smeared on the top conductive side of 2 cleaned and heated ITO slides. Oring acted as a container for the sucrose solution needed for GUV formation. (b) ITO slides
sandwiched as illustrated and AC voltage (2 V) applied with temperature at 60 ± 5°C. Heating
element is not shown here.
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Figure 3: a) Left: Fisher Scientific™ Digital Vortex Mixer Right: Fisher Scientific™ MH Series
Mechanical Ultrasonic Cleaners. b) Left: Benchmark Scientific H3760-HS-E Right: Across
International VO-16020m Bottom: Robinair 2-Stage Vacuum Pump 15500.

9

2.2.3: GUV synthesis
The slide sandwiches shown in Figure 2 were slotted inside an in-house built aluminum
heating block. Electroformation setup is shown in Figure 4. Alligator clips (insulator-coated
outside, red color) were clipped on to the ITO slides and was used to deliver AC voltage
produced by the function generator. Aluminum heating block was heated by dry bath incubator
controlled by Digi-Sense Type-T temperature controller. Function generator was set to 2V @
10Hz for 2 hours and temperature at 60ᵒC. After 2 hours, AC voltage was turned off and
temperature was slowly cooled down to room temperature.

Figure 4: Setup of electroformation method. Function generator operates at 2 V AC voltage, 10
Hz, and a sine waveform for 2 hours. Temperature was set to 60ᵒC for 2 hours and then slowly
cooled down to room temperature. Instruments include Siglent SDG1025 Function Generator,
Digi-Sense T-Type Temperature Controller, and VWR 13259-005 Dry Bath Incubator.
10

2.2.4: Post-Electroformation
After cooling down to room temperature, GUVs were harvested into 100 mM fresh
glucose and 10mM HEPES @ pH 7.0 solution. GUVs were viewed within the day of preparation
itself, but not at least 30 minutes after harvesting. Visit
http://faculty.cas.usf.edu/pan/videos.html for a complete video presentation of the
electroformation method.

2.3: Light Microscopy
Optical microscope is an analytical tool that enables a researcher to view specimen up
to 1000x its original size. Meaningful microscope magnification can go up to 1500x. The
downside to high magnification is low intensity. The principle of a bright filed optical
microscope is fairly simple. Light source emits light rays that are focused by a condenser that
converges on the specimen. Light rays that illuminate the specimen will continue to diverge
past the specimen and be magnified by an objective lens. The image produced by the objective
lens will be inverted. Another lens known as the ocular/eyepiece lens will further magnify the
image into our eyes and correct the inverted image, resulting in an upright final image. Image
magnification can be calculated by multiplying the objective lens and the ocular lens. Figure 5
shows a diagram of the light path in a basic microscope.

11

Figure 5: Basic light path of an optical microscope. Light rays from the light source pass through
the condenser and converge onto the specimen. The light that illuminates the specimen will
reach the objective lens and form a magnified, inverted image. The image is further magnified
by the ocular lens that falls into eyes. Magnification is determined by multiplying objective lens
and ocular lens.

Nikon ECLIPSE Ti-U inverted microscope was heavily employed in this thesis work. Besides
bright filed light microscopy, fluorescent microscopy was also utilized. Fluorescent microscopy
12

has a different light source compared to bright filed light microscopy, a metal-halide lamp. This
light source actually emits from the bottom of the specimen instead from the top in light
microscopy mode. Main components of this inverted microscope will be explained below
(Figure 6).

Figure 6: Nikon ECLIPSE Ti-U inverted microscope showing important components. Andor iXon
Ultra 897 EMCCD is attached on the other side (not visible).

13

2.3.1: Light sources
There are two types of light sources built into this microscope: halogen lamp and metalhalide lamp. The halogen lamp runs on TI-PS 100W power supply for 100-240V. This halogenic
light is used for viewing phase contrast (Ph) and bright-field (BF) of a specimen. In this mode, a
dense area on a specimen will absorb the halogenic light and make that region dark, while the
less dense areas will transmit halogenic light and appear bright. The metal-halide lamp runs on
Prior L200US 250W power supply for 110-240V. This lamp is a type of high-intensity discharge
(HID) gas discharge lamp and is used for viewing fluoro-luminescence specimen, known as
fluorescent microscopy. A specimen needs to be dyed by fluorophores prior to using this
imaging mode. When light hits specimen, areas on the specimen that contain fluorophores will
be excited by the light by absorbing photons, and then re-emitting light with a different
wavelength photons. Figure 7 shows power supplies for both imaging modes.

14

Figure 7: Top shows TI-PS 100W power supply for 100-240V used in bright-field mode. Bottom
shows Prior L200US 250W power supply for 110-240V used in fluorescent mode.
2.3.2: Objective lens
Objective lens is key to magnifying specimens. The objective lens collects light rays from
illuminated specimen and projects an inverted image. We have objective lenses with different
magnifications (4-100x). 4-10x are low powered objectives. These objectives are good for
viewing tissues and selecting regions of interest on a specimen. For high powered objectives,
lenses range from 40-100x. These objectives are used to view cells and submicron specimen. As
magnification increases, resolution length also increases, causing the image to have low
intensity. Because of this, many objectives use fluid-based objectives such as oil-, water-,
glycerol-immersion. The fluid’s large index of refraction helps to gather light rays into the
objective lens, hence increases the intensity. Air-immersion long working distance CFI super
fluor ELWD 60x was used for most of our GUV imaging.
15

2.3.3: Condenser and aperture
Condenser allows light rays to be focused on the specimen. In Nikon Eclipse Ti-U, there
are three imaging modes built into the microscope; BF, Ph, and external phase contrast.
Imaging modes are interchangeable by rotating turret that carries various optical elements.
Aperture diaphragm on the other hand, adjusts the size of field of view. The calibration of
condenser and aperture diaphragm are only important for BF and Ph imaging modes. Most of
this work was done in fluorescent mode.

2.3.4: Specimen stage and preparation
A specimen can be moved in x and y directions when mounted on the stage. Custom
sample chamber was designed to accommodate small working distance of the objective lens.
Sample preparation was done by further diluting harvested GUVs with 100 mM glucose and 10
mM HEPES @ pH7.0 solution and then pipetted to a silicone gel well covered with cover slip on
a glass slide. Cover slip will orient closest to the objective lens. GUVs images were obtained
with Nikon Eclipse Ti-U equipped with Andor iXon Ultra 897 EMCCD camera. Coupled with
highly complementary microscope software (NIS-Element), we were able to record GUV videos
and capture images. 60x objective and 500 ms exposure time were used to take images and
record videos (1 sec interval/frame). GUVs with fully Ld phase, Lo-Ld coexisting phases, and
critical-like fluctuations were observed under fluorescent condition. Ld phase appears bright
due to segregation of rhodamine-DPPE dye in that phase.
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2.3.5: Focusing knob
As the specimen stage allows x and y directions movements, focusing knob allows z
direction movement of the objective lens. Focusing knob displaces the height of the objective
lens relative to the specimen stage. There are two focusing sensitivity, coarse and fine focusing.
Focusing is crucial to bring objective lens to its working distance in order for lens to function
correctly. Since the sample cover slip will be closest to the objective lens, there will be “beadlike” artifacts coming into focus first from coarse focusing. Upon seeing those artifacts, fine
focusing was used to locate GUVs. Majority of GUVs were sunken down at the bottom of the
sample chamber as sample was allowed to sit for 30 minutes prior to imaging.

2.3.6: Temperature-controlled chamber for temperature-sensitive environment
Since studies of GUV phase miscibility transition temperature Tm require stable
environmental temperature surrounding the sample, a temperature-controlled chamber was
machined out of copper to allow for both BF and fluorescent microscopy. The chamber is
heated by a Thermo Scientific Haake ARCTIC A25 coupled with an AC 150 Immersion Bath
Circulator. A water canal was machined inside the chamber and is connected to the bath
circulator. A temperature probe (Type T) was used to measure the temperature of the sample.
The probe was directly inserted into the sample solution via a small hole drilled through a
plastic microscope slide. Temperature was read by Digi-Sense Temperature Controller (see
Figure 4). Figure 8 shows the physical placing of chamber on the specimen stage. This in-house
observation chamber was able to acquire down to 0.1ᵒC precision.

17

Using this observation chamber, Tm study was performed for M2TM, tamoxifen, genistein,
verapamil and pure lipid mixtures. Polyphenol molecules and M2TM (by mol%) were added to
lipid mixtures prior to electroformation to obtain appropriate GUVs for experiments. To avoid
Tm hysteresis (i.e., Tm could be different depending on heating or cooling GUVs), all
temperature ramping experiments were done by cooling from high to low temperatures.

Figure 8: a) Left: Copper temperature-controlled chamber with a removable top. Water tubes
are connected to bath circulator. Right: Placement of temperature-controlled chamber on top
of the specimen on the stage. The top can be removed to allow for BF imaging. b) Thermo
Scientific Haake ARCTIC A25 coupled with AC 150 Immersion Bath Circulator used for heating
and cooling. Ultrapure water (18.2 ΩM-cm) was used as circulatory heating fluid.
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2.4: Atomic Force Microscopy
Atomic force microscope (AFM) is a powerful analytical tool because it can acquire
nanoscale three-dimensional specimen topography as well as material properties (e.g., Young’s
modulus). The first AFM was invented by Binnig et al. in 1986 [11]. AFM scans sample surface
through a probe known as the “tip”. This tip is attached to a cantilever arm which has a
deflective surface on the opposite side of the tip, on the cantilever arm. The deflective surface
acts to deflect the laser beam focused on the top of the tip and the deflected beam is detector
by a photodiode. As the tip scans across, height difference on the specimen surface will move
the tip in the z-direction, hence moving the laser detected by the photodiode and result in a
topographical map. Since the tip will be nanometers away from the surface, there are few
forces that deflects the cantilever arm. These forces are repulsive force, electrostatic attractive
force, and capillary force (in fluid). Ever since the invention of AFM contact mode, more
imaging modes have been introduced. There is now non-contact mode, tapping mode,
PeakForce quantitative nanomechanics (QNM) mode, and many more. To complement GUVs
studies, we also used a fluid-compatible Multimode 8 AFM from Bruker to measure planar lipid
bilayer topography in response to foreign molecules [12, 13]. Figure 9 shows an example of
height images for a ternary lipid system exhibiting large and small phase separation near the
critical point [14].
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Figure 9: Height images of a ternary lipid system (DOPC/ESM/Chol) taken from “Macroscopic
and Nanoscopic Heterogeneous Structures in a Three-Component Lipid Bilayer Mixtures
Determined by Atomic Force Microscopy” paper [14]. Lipid compositions are indicated by the
ratio of DOPC:eSM + cholesterol mole percentage. Scale bars are 200 nm.
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CHAPTER THREE:
GIANT UNILAMELLAR VESICLES

3.1: Brief introduction to phospholipid and lipid bilayer
Cellular membranes (e.g., outer plasma membranes and inner membranes enveloping
nucleus, mitochondria, Golgi apparatus, and endoplasmic reticulum, etc.) contain many lipid
species, including fats, sterols, phospholipids, mono-/bi-/tri-glycerides, sphingolipids,
gangliosides, and many more. Despite the diversity of lipid species to choose from, it is wellknown that phospholipids are the most abundant lipids that constitute a cell membrane.
Phospholipids are generally separated into two regions: polar hydrophilic headgroup and two
hydrophobic fatty acid chains aka acyl chains (Figure 10). The hydrophilicity of the headgroup is
due to the negatively charged phosphate group. This phosphate group is also connected to a
glycerol backbone. On the other hand, the acyl chains are uncharged, therefore do not have an
affinity towards aqueous solution like water. Within the acyl chain, there are saturated (single
bonds) and unsaturated (double bonds) carbon bonds. The region on membrane where it is
made up of saturated acyl chains is generally stiffer than the region with unsaturated chains.
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Figure 10: Chemical structure of a phospholipid. Hydrophilic headgroup is composed of choline
(red circle), phosphate (green circle), and glycerol (yellow circle). Hydrophobic acid chains can
be either saturated (left) chain or unsaturated (right) chain with double bond (blue circle)
making a “kink” in the chain. Image source:
http://myhome.sunyocc.edu/~weiskirl/lipids_membranes.htm

When lipids self-assemble, the hydrophobic tails will tend to group together (away from water),
leaving headgroup exposed to the aqueous solution. This amphipathic behavior of lipids leads
to the natural formation of membranes. There are different morphologies for lipid membrane
structures, including liposome, bilayer sheet, and micelle, to name a few. In this work, the
structure of liposomes best resembles cell membranes and was therefore utilized. Recently,
Beltramo et al. developed a free-standing model of lipid membranes [15]. This model allows
probing on both sides of the membrane as oppose to the older models mentioned above.
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As mentioned in Chapter 1, the function of cell membranes is to keep foreign molecules out
and protect important organelles for the cell to operate properly. Cell membranes also function
as a “gate” to allow smaller molecules to past through for important cellular processes. It is
helpful to determine a reasonable lipid composition for in-vitro model membrane. GUV
formation and imaging are explained in Chapter 2. Phase separation is observed in many
electroformed GUVs. Also, there is a corresponding correlation between the amount of
saturated lipid presenting in GUVs to the surface area of Lo. Lastly, the phase miscibility
transition temperature Tm of GUVs composed of 3:2 DOPC/ESM + 32mol% Chol was determined
to be 32.7ᵒC.

3.2: Phase separated GUV behavior
GUVs have become a favorable model for many contemporary studies of lipid
membranes since early 1970s [5]. It is clear that phase separation was observed in ternary
system GUVs. Prior to using DOPC/ESM/Chol mixtures, alternate mixtures containing POPC
were investigated (i.e., POPC/brain-sphingomyelin/Chol). It was revealing to find that POPCcontaining mixtures posed issue for phase separation study as it is homogenous under
fluorescence microscopy. The nano-scale phase separation behavior can only be unveiled by a
much more powerful tool, such as AFM. We have conducted an experiment of a fourcomponent lipid bilayer system (DOPC/POPC/brain-sphingomyelin/Chol) with DOPC slowly
replacing POPC and confirmed that DOPC induces micro-structure while POPC induces nanostructure [16].
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The difference between DOPC and POPC is found in the hydrocarbon chains. POPC contains one
unsaturated (C=C double bond) acyl chain and DOPC contains two unsaturated acyl chains.
These unsaturated acyl chains are what makes membrane tight packing hard [17].
Sphingolipids (egg-sphingomyelin and brain-sphingomyelin) contain saturated acyl chains that
are ideal for order and tight packing. In general, the unsaturated acyl chains like to stay with
unsaturated chains, and saturated chains will like to stay with saturated chains. Therefore,
DOPC will mix poorly with sphingolipids, while POPC will have better mixing tendency with
sphingolipids. This qualitatively explains why large phase separation is observed in DOPCcontaining mixtures, but not in POPC-containing mixtures.

During observation, not all GUVs from the same sample display the same phase behavior. Some
would have more Lo domain surface area than others, and some would not phase-separate at
all. This is due to the compositional heterogeneity that exists during the process of
electroformation [18]. On a different note, a group has shown that domain formation can also
be photo-activated if GUVs are exposed to light for some time [19]. Finally, Tm of a lipid
composition differs as temperature ramping path follows a hysteresis loop [20]. To tackle the
first issue, over 30 individual GUVs were recorded that display similar phase behavior at a given
temperature to ensure bulk phase behavior of that sample. Next, exposure of GUVs to
fluorescent light was limited by only focusing on small area of the glass slide and blocking off
the light when not imaging. Temperature ramping pattern has been kept the same for all Tm
study (from high to low temperature) to ensure all Tm are on the same side of the hysteresis
loop. Another countermeasure that was taken was to make a control sample every time we
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made a new lipid composition. The control sample acts as a reference point to connect all lipid
compositions.

3.3: Lipid compositions
The work of increasing sphingolipid (i.e, ESM) ratio in the lipid mixture of
(DOPC/ESM/Chol), shows increase of surface area of tightly packed Lo phase [14]. This Lo phase
corresponds to the dark region in Figure 11. Contrary, the loosely packed unsaturated DOPC
enriched Ld phase corresponds to the bright region under fluorescent microscopy in Figure 11.
The brightness of Ld phase comes from the rhodamine-DPPE dye, which preferentially partitions
into the Ld phase.

Figure 11: Above shows fluorescence GUVs (@27°C) of various DOPC:ESM ratio +20mol% Chol;
(A) 3:1; (B) 2:1;(C) 12:7; (D) 3:2; and (E) 1:1. Ld phase dominates at low ESM content, while Lo
phase increased as ESM content increased.
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Though the surface area fraction of Lo/Ld phase is not prominent in Figure 11, one can still see
the gradual area fraction increase from 3:1 to 1:1 ratio. Lo surface area fraction drastically
increased as ESM is added past 1:1 ratio, which served as a threshold ratio for L o phase
domination, shown in Figure 12. GUVs did not become one Lo phase despite fourfold ratio of
ESM to DOPC (Figure 12C). GUV appears to have two kinds of Lo domains; hemispherical
capped and island-like. Images of these GUVs were taken several hours post-electroformation
and at room temperature (27°C). GUV studies in this section were all observed in room
temperature unless stated otherwise. This can mean given enough time for lipids to
agglomerate, a single large Lo domain is more favorable than many Lo domains.

Figure 12: Above shows fluorescence GUVs in ternary lipid mixture of DOPC:ESM+cholesterol in
various DOPC to ESM ratio; (A) 1:2; (B) 1:3; and (C) 1:4. Cholesterol concentration was held at
25%. Lo phase dominates at high ESM content.
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3.4: Effect of cholesterol on GUVs
The exhausted study of saturated-unsaturated lipid mixtures led to the examination of
cholesterol effects in GUVs. GUVs of DOPC/ESM ratios 1:1, 3:2, and 2:1 were examined with
various cholesterol %. For 1:1 ratio, 20% Chol seems to produce a hemispherical L o phase that
persists even at 30% Chol (Figure 13B, C). At 38% Chol, the well-defined boundary between Lo
and Ld phases deconstruct into coexisting undulation of Lo-Ld (shown in Figure 13E). As Chol
content increased to 42%, GUVs developed into a homogenous Lo phase (Figure 13F).

Figure 13: Above shows fluorescence GUVs in ternary lipid mixture of (1:1) DOPC:ESM in
various Chol concentration; (A) 10%; (B) 20%; (C) 30%; (D) 35%; (E) 38%; (some GUVs may
display compositional deviation); and (F) 42%-one Lo phase. Images of GUVs were taken at room
temperature (27°C).

Evidently, addition of Chol increases Lo surface area which is similar to addition of ESM. For 3:2
ratio, critical fluctuation occurs at 35% Chol (Figure 14E) while homogenous Lo phase occurs at
38% Chol (Figure 14F).
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Figure 14: Above shows fluorescence GUVs in ternary lipid mixture of DOPC/ESM 3:2 in various
Chol concentration; (A) 5%; (B) 10%; (C) 20%; (D) 30%; (E) 35%-critical fluctuations; and (F) 38%one Lo phase. Images of GUVs were taken at room temperature (27°C).

The trend follows as critical fluctuations for 2:1 ratio decreased down to 33% Chol (Figure 15D)
and homogenous Lo phase at 35% Chol (Figure 15E). A summary of various lipid ratios
experiencing critical fluctuations is shown in Figure 16. These critical fluctuations are in
submicron scale and have irregular shapes. The irregular shapes arise from the high
maneuverability of the Lo-Ld undulation compared to low maneuverability of distinct phase
separation.
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Figure 15: Above shows fluorescence GUVs in ternary lipid mixture of DOPC/ESM 2:1 in various
Chol concentration; (A) 10%; (B) 20%; (C) 30%; (D) 33%-critical fluctuations; and (E) 35%-one Lo
phase. Images of GUVs were taken at room temperature (27°C).

Figure 16: The fluorescence GUVs showing critical fluctuations at different ternary lipid
mixtures of DOPC:SM + %Chol at room temperature (27°C); (A) 3:1+30%; (B) 2:1+33%; (C)
12:7+36%; (D) 3:2+35%; (E) 6:5+37%; (F) 1:1+38%.
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The finding in Figure 14 shows that addition of cholesterol enhances the surface area of Lo
domain. Since the majority of cholesterol is associated with the Lo phase, it seems that the rigid
ring structure of cholesterol is more compatible with saturated sphingolipids, resulting in
decreased mobility of the acyl chains of sphingolipids [21] (Figure 17). It has been proposed
that the small polar head of cholesterol is what allows it to orient itself close to the membrane
surface and next to the phospholipid headgroups [22]. Cholesterol-saturated lipid interaction
has also been attributed to strong hydrogen bond between those two [23].

Figure 17: Cartoon model of ideal lipid bilayers composing of phospholipids (blue circle), acyl
chains (red lines), and cholesterol (orange hexagons). Saturated acyl chains are more structured
compared to its surrounding unsaturated acyl chains. This structural integrity stiffens Lo
domains, while leaving Ld lipids to move freely around it.
3.5: Tm study of GUVs
Miscibility transition temperature Tm is the temperature where phase separated lipid
bilayers become homogeneous. To find this phase coexistence, 3:2 (DOPC:SM) + 32% Chol
GUVs were used. Given the imperfection of lipid organization, each GUV in the same batch will
not be truly homogenous in terms of the lipid content. For this fact, one can obtain small

30

variation of Tm in the same batch of GUV. The way Tm was extrapolated was by taking the
average of two temperatures: the temperature when majority of GUVs show critical-like
fluctuations (at the verge of miscibility transition temperature) and the temperature when
GUVs show homogenous Ld phase. Critical-like fluctuations were found to be at 31.7°C with
32% Chol as opposed to 27°C for 35% Chol. So it seems the reduction of cholesterol resulted in
temperature increase in order for GUVs to display critical-like fluctuations. Vice versa, the more
cholesterol content, the smaller Tm becomes.

Figure 18: Above shows fluorescence GUVs temperature ramping of (3:2) DOPC:SM + 32% Chol;
(A) 23.0°C; (B) 30.5°C; (C) 31.7°C-critical fluctuations; and (D) 35.8°C -one Ld phase.
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As for the interaction between Lo domains and their surrounding Ld phase, the boundary is
regulated by hydrophobic mismatch [25]. The Lo-Ld height difference is well established by
many studies [16, 25-28]. At the boundary, Lo domain gradually decreases its height to meet
with the surrounding Ld phase (smaller height) [25]. This way, the hydrophobic acyl chain of
ESM on domain perimeter will not be exposed to the aqueous environment, i.e., less
unfavorable energetic cost [25]. The energy per unit length at domain perimeter due to lipid
bending and splaying is called line tension [29]. In other words, hydrophobic mismatch at the
Lo-Ld boundaries determines line tension. Not only that, it is favorable for lipid bilayers to
minimize line tension by merging multiple domains into a single giant domain over time (i.e.,
smallest domain perimeter when all domains are merged together). This is the reason why
most GUVs display polarized domain (Figure 11). As temperature approaches Tm (from the low
end), hydrophobic mismatch becomes smaller and ultimately line tension drops down to 0 at
critical fluctuation regime. Figure 18 images reflect the decrease in line tension as temperature
approaches Tm.

Furthermore, Veatch et al. has shown substituting brain-sphingomyelin (BSM) with eggsphingomyelin (ESM) increases miscibility transition temperature of GUVs [18]. This means that
ESM-membranes will have more stable and closely packed domains compared to those formed
by BSM-membranes [17]. Also, ESM-membrane Tm allows domain formation at a wider range of
temperature below Tm compared to BSM-membranes. Hence ESM was adopted instead of BSM
for ternary mixture. The reason for choosing 32% cholesterol was because it falls in the liquid-
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liquid coexisting region at room temperature, and the Tm at this cholesterol content is of easy
reach with our setup.
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CHAPTER FOUR:
TRANSMEMBRANE DOMAIN OF THE INFLUENZA A PROTEIN

4.1: Brief introduction of M2TM
“Flu” is one of the oldest human companions. It is a viral infectious disease that infect,
mostly, upper respiratory tract. In humans, flu is caused by influenza A virus. Viral envelope
carrying influenza A virus enters the respiratory airway and binds to cellular membranes via
viral peptide. Of course, a healthy cell does not suddenly become sick when the viral envelope
gets inside host’s cytoplasmic space, it is actually the release of viral code inside the viral
envelope into the cytoplasmic space that infects the host cell. This viral envelope breakdown is
heavily dependent on the M2 protein [30]. M2 functions to acidify viral interior to assist in
envelope breakage [30]. Structurally, the transmembrane domain of M2 (M2TM) forms a tetraoligomeric channel that allows proton transport into the viral envelope. The way protons are
conducted is mediated by histidine residue (H37), which is located in the transmembrane
region of M2TM [31]. Meanwhile, tryptophan residue (W41) functions as the channel gate for
proton transport and is located close to the interior leaflet of viral envelope [31].

There exists enormous amount of structural studies on M2TM, but not so much on M2TM
effects on critical-like fluctuations of lipid membranes. Critical-like fluctuations represent a
special ability of cell membranes to modify their lipid composition at certain temperatures to
34

accommodate for important bioprocesses [32]. So it is significant to study how M2TM may
change this innate ability of lipid membranes. M2TM peptide was incorporated into GUVs in
this study. We find that inclusion of M2TM increases Tm. Not only that, smaller vesicle budding
was also observed in M2TM-treated vesicles.

4.2: M2TM membrane addition approach
Two approaches were used for mixing M2TM into lipid bilayers. In the first approach,
M2TM was mixed with pure lipid mixtures with desired mole ratios prior to being
electroformed. The M2TM-incorporated GUVs of post-electroformation was then pipetted to
silicone gel well for observation. The second approach was done by suspending M2TM in GUV
buffer with 1% (v/v) DMSO. Equal volume of lipid-only GUVs and M2TM solution were pipetted
into a micro-centrifuge tube (1.5 ml) and allowed to incubate for 20 minutes. After incubation,
the mixture was pipetted into a silicone gel well for observation. We had also tested mixture of
GUVs and DMSO as a control. For the second approach, DMSO concentration is 0.5% (v/v) and
M2TM concentration is 2.3 µM.

4.3: Tm study for GUVs with M2TM
Phase miscibility transition temperature Tm for GUVs composed of (3:2) DOPC:ESM +
32% Chol was explored as a function of M2TM content. Figure 19 shows GUV miscibility
transition temperature when there is 4mol%M2TM. The estimated Tm is 37 °C, which is ~5°C
larger than that of GUVs without M2TM. We also performed Tm study for 1% to 8% M2TM, as
shown in Figure 20 and Table 1. Tm increases steadily by 1-2 °C per 1% M2TM from 0% (32.7°C)
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to 8% (48.5°C). This shows M2TM peptide indeed affects the mixing capability of lipids, i.e.,
more energy is needed to mix as M2TM % increases. Below Tm, GUVs of all M2TM % display Lo–
Ld phase separation. Phase separation becomes more prominent as the temperature drops
away from Tm.

Figure 19: Above shows temperature ramping of fluorescent GUVs of (3:2) DOPC:ESM +32%
Chol +4%M2TM; A) 23.0°C; (B) 37.0°C-critical fluctuations; and (C) >40.5°C-one Ld phase.
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Figure 20: Above shows critical-like fluctuations of fluorescent GUVs of (3:2) DOPC:ESM +32%
Chol +various %M2TM. The mole fraction of M2TM is (A) 1%(33.2°C); (B) 2%(34.5°C); (C)
4%(37.0°C); (D) 5%(39.7°C); (E) 7%(45.2°C); and (F) 8%(48.5°C).

Table 1: Summary of Tm of various M2TM % in 3:2 DOPC/ESM + 32%chol GUVs. Tm increases as
M2TM % increases.
3:2 DOPC/ESM + 32%chol + M2TM %
1
2
4
5
7
8

Tm
33.2°C
34.5°C
37.0°C
39.7°C
45.2°C
48.5°C

The Tm increase in M2TM-incorporated vesicles is probably due to the partition of M2TM into Ld
phase. This affinity is shown through our AFM study where we observed individual M2TM
oligomers localized in the Ld phase [12]. Many factors could contribute to the phase dependent
partitioning of M2TM. One possible explanation is that the length of M2TM is more compatible
with the Ld phase than with the Lo phase. M2TM partitioning to the Ld region implicates a large
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energy barrier between the Lo and Ld phases. This supports data of Tm increase as higher
thermal energy (temperature) will be needed to cross the phase boundaries.

4.4: Vesicle budding
A group from University of Illinois has shown formation of smaller vesicles from parent
GUVs, termed as “budding”, with addition of pore-forming peptide is possible [33]. As has been
shown by Rossman et al., M2TM is also capable of inducing vesicle budding [34]. We also
studied whether M2TM can induce vesicle budding when there is Lo-Ld phase separation. The
experiment was performed at 23°C for many M2TM concentrations, except for 1% M2TM. For
1% M2TM, GUV budding was observed at 33.2°C. Take 2% M2TM for example, small vesicles
are observed to bud from parent GUVs with Lo and Ld phase coexistence (Figure 21). Vesicle
budding persists for 4%, 5%, 7%, and 8% of M2TM (Figure 21). No budding was observed in 6%
M2TM. An explanation for the lack of budding at 6% M2TM might just be due to sample
preparation issue. Some parent GUVs also contain smaller vesicles inside them due to internal
budding (Figure 21A-B).
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Figure 21: Above shows vesicle budding for 3:2 DOPC:ESM +32% Chol + various % M2TM at
23ᵒC; (A) 1% (@33.2ᵒC); (B) 2%; (C) 4%; (D) 5%; (E) 7%; and (F) 8%. For 7%, reverse budding
were observed as Ld buds off vesicles instead of Lo domains.

To study if cholesterol plays a role in GUV budding, GUVs composed of 3:2 DOPC:ESM with 8%
M2TM in various (2, 5,10,20) mol % cholesterol were concocted. The immediate observation is
a third phase known as the gel (or solid) phase in place of the Lo phase (Figure 22). Gel phase is
irregularly shaped compare to circular domains of the Lo phase. Gel phase is only present in
GUVs containing 2 and 5 mol % of Chol. Budding is observed in all cholesterol mol %. Hence the
amount of cholesterol plays insignificant role in GUV budding.
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Figure 22: Above shows GUVs of 3:2 DOPC:ESM + 8% M2TM + various % Chol at 23ᵒC.
Cholesterol mole fraction is (A) 2% and (B) 5%. Low cholesterol content changed Lo domains to
irregular shaped gel structure. Vesicle budding occurs at all % Chol (data are not presented).

M2TM study so far has been examined under peptide exposure with pre-electroformed lipid
mixture. To test if M2TM can induce vesicle budding for lipid-only GUVs, we added M2TM
dissolved in 1% DMSO to post-electroformed GUVs at 27°C. Addition of 1% DMSO only led to
critical-like fluctuations at a lower temperature (27°C) of GUVs (Figure 23B). No budding is
observed. Hence DMSO alone is incapable of inducing membrane budding. We noticed
significantly more GUVs experiencing budding if DMSO + M2TM are added to lipid-only GUVs
(Figure 23C). Also, the buddings are more distinct compared to Tm study of M2TM.
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Figure 23: Above shows effect of DMSO and M2TM addition to lipid-only GUVs of (3:2)
DOPC:ESM +32% Chol; (A) pure lipid; (B) 1% DMSO (27°C); and (C) 1% DMSO + 2.3 µM M2TM
(budding).

M2TM has an intrinsic ability to form tetramer. This tetramer when planted into lipid
membranes causes vesicle shape restructuring. The structure of tetramic M2TM is conical with
tilt about 22-32° with respect to the bilayer normal [12]. The conical tetramer structure will
have narrowed N-terminal and widened C-terminal. Some has reported tilt angle as large as 3038° [35]. The tilt angle variation is believed to be caused by the length mismatch of hydrophobic
thickness of different membranes and M2TM height. Within the hydrophobic region of lipid
membranes, the insertion of M2TM will cause tight packing to lipid around its C-terminal
compared to its N-terminal. This involuntarily shoving of lipids brings about nonsymmetrical
lipid leaflet arrangement that will induce negative membrane curvature. The symmetrical
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insertion of M2TM (Tm study) is why we don’t see assortment of budding in M2TMincorporated vesicles prior to electroformation. This is because the conical shape M2TM
tetramer paired with symmetrical orientation will cancel out any negative curvature. On the
contrary, we see a lot of budding when we introduced M2TM to lipid-only GUVs postelectroformation (Figure 23C). These budding can only mean that M2TM preferentially insert
itself in one orientation more than the anti-symmetrical orientation, if added postelectroformation. One disagreement with Rossman et al. is the effect of cholesterol on vesicle
budding. They reported that low cholesterol+M2 content induces budding and no budding is
observed at high cholesterol+M2 content [4]. Contrary, our results tell us that cholesterol plays
no role in GUV budding.

Also, our AFM data (not presented) showed that M2TM only affected lipid lateral packing and
not the height of each phase. M2TM in the Ld phase increases the stiffness of that phase. The
increase in Ld phase rigidity modifies line tension at domain edges. Since vesicle budding is
related to domain line tension and the bending energy of budding caps, our AFM data might
explain GUV budding.
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CHAPTER FIVE:
POLYGLUTAMINE AGGREGATES

5.1: Brief introduction of polyglutamine
Huntingtin (htt) is the protein that is notoriously known to cause Huntington’s disease
(HD) in human [36-42]. The N-terminus of htt contains a stretch of glutamine amino acids (i.e.,
polyglutamine). The number of the consecutive glutamine amino acids was found to correlate
with the onset age of HD, as well as the severity of the disease. Generally speaking, the longer
the polyglutamine (polyQ) stretch is, the earlier the disease manifests itself. Moreover, when
the number of glutamine is < 35, no risk of HD has been found. It seems that there is a
pathologic threshold of the polyQ length [43], below which the protein is harmless and above
which there is a high risk of developing the progressive neurodegenerative HD.

In HD affected patients, large aggregates of htt, the so-called inclusion bodies, have been found
in various areas of dead neurons. Many biophysical and biochemical studies have shown that
depending on its length, the polyQ stretch has an intrinsic tendency to aggregate into oligomers
and fibrils. The similarity between polyQ aggregates and the inclusion bodies, as well as the
cytotoxicity of polyQ aggregates to cultured neutrons and animal models, has led researchers
to propose that polyQ is the main culprit in HD.
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Despite intense research, the mechanism of polyQ mediated cellular toxicity is unknown.
Several membranous targets by polyQ aggregates have been proposed, including nucleus
membrane, mitochondrial inner and outer membranes, and synaptic plasma membrane. We
are interested in how polyQ aggregates impair lipid membrane structure and morphology [13].
This thesis work focuses on the effect of aggregates formed by a polyQ peptide (KK-Q35-KK, 35
glutamine flanked by two lysine at each end) on GUVs. GUV disruption was observed in all
vesicles with addition of polyQ, as predicted. The insight of polyQ’s dynamic with lipid
membranes will be of significant application to therapeutic strategies.

5.2: PolyQ membrane addition approach
For polyQ study, two GUV compositions were used: pure DOPC and DOPC/ESM/Chol
mixture. In both cases, polyQ aggregates were prepared by incubation in 10 mM HEPES pH 7.0
at room temperature. Aggregate formation was monitored by AFM and Fourier transform
infrared spectroscopy measurements (data not shown). After confirming aggregate formation,
polyQ aggregates were suspended in GUV buffer and mixed with lipid GUVs at equal volume. In
other words, the polyQ solution was pipetted into GUV solution on a glass slide for imaging.
Immediately after polyQ addition, fluorescence images were taken and GUVs showed no
evidence of membrane disruption. For control experiment, GUV was mixed with buffer-only
solution and imaged. All images of vesicle disruption obtained in this study were using 15 µM
polyQ peptide and taken 10 minutes after addition.
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5.3: PolyQ induces vesicle disruption
PolyQ effect on lipid membranes was first studied on single lipid GUVs made of DOPC
(Figure 24A). Upon adding equal volume of 15 µM polyQ aliquot (incubated for five days at 4°C)
to intact homogenous GUVs, no vesicle breakage was observed instantaneously. Peptide
aliquot that was incubated for five days contains many oligomeric and fibrillar aggregates,
according to our AFM data [13]. However, based on the observation that very small number of
GUV breakage can be caused by directly pipetting polyQ aliquot against the GUV aliquot on a
glass cover slip, we used a modified approach where GUV + polyQ aliquots were mixed in a
microcentrifuge tube and let alone to incubate for 10 minutes. This approach significantly
reduces artifacts associated with the pipetting procedure. Using the modified approach, we
observed that GUV breakage left a residual on the glass slide that is detectable through
fluorescence microscopy. The residual appears to be non-circular in shape and is generally
larger in size compared to its former intact GUVs (Figure 24A:1-3).

Figure 24: Above shows fluorescent GUVs vesicle breakage upon addition of polyQ (15µM) to:
(A) Pure DOPC (before polyQ); A1-A3 (polyQ added) and; (B) 3:2 DOPC:ESM+20% Chol (before
polyQ); B1-B3 (polyQ added). Breakage occurred about 10 minutes after polyQ aliquot added.
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Ternary lipid mixture of 3:2 DOPC:ESM+20%Chol was investigated to see how polyQ affects
phase-separated GUVs (Figure 24B). Similar shape and size vesicle breakage was observed 10
minutes after polyQ addition. But interestingly, the residuals from phase-separated GUVs kept
their phase separation behavior even after vesicle breakage (Figure 24B:1-3).

The toxic severity of polyQ to lipid membrane draws from its own polyQ length repeat
(extension) and aggregation [13, 36]. PolyQ repeats start at the N17-terminal of htt protein. It is
headed by an N17-terminal (mainly α-helix) and is flanked by polyproline at C-terminal
downstream [41, 42]. According to molecular dynamic simulations by Nagarajan et al, the
combination of N17 and polyproline is key to how deep polyQ penetrates the membrane [44].
Their work also shows membrane thinning simulation data. Membrane thinning occurs in
regions that contain polyQ [44]. It is safe to say then that membrane thinning can and will result
in membrane disruption. Another group shares similar result with Nagarajan’s group. N17terminal of htt proves to be important not only to provide site for polyQ repeats, but also vital
for polyQ–lipid membrane binding [45]. They presented the inhibition of N17-terminal ability to
bind to lipid membrane by altering N17-terminal [45]. Kim’s group reported that polyQ repeats
can adopt α-helix, coil or extended loop structure [41]. They also proposed that a long (>35Q)
polyQ extension will encourage the aggregation of other peptide or another extended-polyQ
structure [41]. This aggregation will have pathogenic consequences on lipid membrane such as
membrane disruption. Oligomer aggregate of about 6-7 monomers was reported to disrupt
solid supported lipid bilayer through a two-step process, consistent with GUV result in this
thesis work [42].
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On a different note, the presence of cholesterol is shown to decrease polyQ binding to lipid
membranes [46]. Cholesterol stiffens lipid membrane and thus reduces efficiency of polyQ to
penetrate through. Contrary, our GUV data shows disrupted membrane vesicles for both pure
DOPC and DOPC/ESM/Chol. This discrepancy may be due to different lipid species used and
techniques employed. However, it does compel a future study of different cholesterol
concentration vesicles with polyQ. One can look at the percentage of vesicle breakage and time
it takes for the breakage to occur. Lastly, Chaibva et al claimed that polyQ preferentially
accumulate around curved lipid membranes [47]. Chaibva finding is not covered in this work
and will requires further study.
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CHAPTER SIX:
POLYPHENOL DRUG MOLECULES

6.1: Brief introduction of tamoxifen, genistein, and verapamil
Of the plethora anticancer drugs used to treat breast cancer, tamoxifen, an amphiphilic
molecule, has been well accepted for its use of prevention and treatment [48]. The way
tamoxifen inhibit breast cancer is by competitively bind to estrogen-receptor binding sites [49].
By binding to estrogen-receptor binding sites, tamoxifen disrupts the cancer cell replication
cycle. On the flip side, tamoxifen has also been shown to inhibit estrogen-receptor-negative
breast cancer cells, cause liver toxicity, and antagonize protein kinase C [50-52]. Protein kinase
C is key to cellular growth regulation and natural apoptotic process [53, 54]. To date, there exist
numerous studies on tamoxifen-membrane interactions using fluorescence anisotropy,
differential scanning calorimetry (DSC), and Fourier transform infrared (FTIR) spectroscopy.
From these studies, physical and chemical properties of lipid membrane were shown to be
affected by tamoxifen [55-59]. Therefore, it is deserving to know how Tm changes with
tamoxifen concentration in lipid model membrane. Tamoxifen-premixed GUVs generally shows
increased Tm with tamoxifen concentration, in this work.

Unlike tamoxifen, genistein and verapamil studies were ephemeral. Genistein is an isoflavones
that function as estrogen receptor [60, 61]. Akin to tamoxifen, genistein can also inhibit various
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cancer cell including breast cancer [62]. Aside from that, genistein is able to avert osteoporosis
[63]. Verapamil is an antihypertensive drug that blocks the transport of calcium through
transmembrane calcium channels [64]. It is commonly used to treat angina, arrhythmia,
hypertension, and hemodynamics. Verapamil’s structure is somewhat linear with a ring flanking
at both ends of the carbon chain. Figure 25 shows chemical structure for tamoxifen, genistein
and verapamil. On a whole, study of drug molecule affecting lipid membrane permeability is
crucial because membrane poses as the first line of defense that any molecules will have to
cross to get inside the cell. Though only two concentrations of genistein were studied,
genistein-incorporated GUVs displays increased Tm compared to genistein-absent GUVs. As for
verapamil, data shows no Tm change between verapamil-incorporated GUVs and verapamilabsent GUVs.

Figure 25: Chemical structure of: a) tamoxifen; b) genistein; and c) verapamil.
Image source: http://sigmaaldrich.com
49

6.2: Tm study of polyphenol drug molecules
Tm study of drug molecules interacting with lipid membranes is the final work of this
thesis. Tamoxifen was added to (3:2) DOPC:ESM +32% Chol lipid mixture before GUV formation
using the electroformation method. We found that 4% tamoxifen increases GUVs Tm by about
3°C compared to lipid-only GUVs (Figure 26). Overall, as % tamoxifen increases, Tm increases by
about 1°C for 1% tamoxifen increment. A summary of Tm for 2, 4, 5, and 6% tamoxifen is shown
in Figure 27 and Table 2.

Figure 26: Above shows temperature ramping of fluorescent GUVs of (3:2) DOPC:ESM +32%
Chol + 4% tamoxifen, (A) 27.0°C; (B) 36.5°C-critical-like fluctuations; and (C) >37.4°C-one Ld
phase. One may note that critical-like fluctuations shown here resemble microdomains.
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Figure 27: Above shows critical-like fluctuations of fluorescent GUVs of (3:2) DOPC:ESM +32%
Chol + various % tamoxifen. The mole fraction of tamoxifen is (A) 2% (33.9°C); (B) 4% (36.5°C);
(C) 5% (36.7°C); and (D) 6% (37.7°C). For 8% tamoxifen, due to the lack of critical-like fluctuation
images, Tm (@37.9°C) was taken as the average of two temperatures, one from homogenous Ld
phase GUVs and the other phase-separated GUVs.
Table 2: Summary of Tm of various tamoxifen % in 3:2 DOPC/ESM + 32%chol GUVs. Tm increases
as tamoxifen % increases.

3:2 DOPC/ESM + 32%chol +
tamoxifen %
2
4
5
6
8

Tm
33.9°C
36.5°C
36.7°C
37.7°C
37.9°C

Tamoxifen is believed to have lipid membrane rigidifying ability, similar to many flavonoids. We
have reported an increased lipid membrane hydrocarbon chain thickness about 2.8 Å with
tamoxifen’s presence [65]. This is because tamoxifen locates itself within lipid membrane
hydrophobic region [65]. Based on the observation that tamoxifen increases GUV Tm, it is likely
that tamoxifen preferentially partitions into one phase versus the other (similar to M2TM).
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Only 4 and 6% genistein were studied. Figure 28 shows critical-like fluctuations at 33.1°C for 6%
genistein. Due to the lack of images with critical-like fluctuations for 4% genistein, Tm was taken
as the average of two temperatures: a high temperature corresponding to homogenous L d
phase GUVs and a low temperature corresponding to phase-separated GUVs. Tm was taken to
be 33.5°C for 4% genistein, which is similar to 6%. Despite an increase in Tm with genistein
addition (~2°C) compared to lipid-only GUVs, result is inconclusive due to lack of studies on
other genistein %.

Figure 28: Above shows temperature ramping of fluorescent GUVs of (3:2) DOPC:ESM +32%
Chol+6% genestein; (A) 27°C; (B) 33.1°C-critical-like fluctuations. and (C) >34.8°C-one Ld phase.

Though genistein Tm study is inconclusive, it is predicted to follow the trend of tamoxifen as
genistein has similar properties to tamoxifen; genistein binds within hydrophobic region close
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to the polar headgroup of lipid membranes and is capable of stiffening lipid membranes [9, 66].
Another group reported the same genistein-membrane behavior. They said genistein decreased
motional freedom of membrane polar headgroups, resulting in a more ordered membrane
structure [67]. Additionally, genistein binding is also regulated by pH of vesicles’ environment
[68].

As for verapamil, 2, 4, and 8% verapamil were concocted into GUVs. Figure 29B shows criticallike fluctuations at 31.3°C for (3:2) DOPC:ESM + 32%chol + 4% verapamil. GUVs develop into
homogenous Ld phase above 33.7°C (Figure 29C). For 2% verapamil, Tm (@31.3°C) was taken in
the same way as 4% genistein for the same reason. Similarly, 8% verapamil showed Tm at 31.4°C
(Figure 30). A summary of verapamil Tm is given in Table 3. Comparing this result with that of
lipid-only GUVs of the same lipid compositions, verapamil appears to have no effect on Tm.
Based on the augmented Tm in the presence of M2TM and tamoxifen, it is possible that
verapamil does not have a strong preference for Lo or Ld phases. Meier et al. reported that
verapamil mostly exists in a charged state at pH7.4 [69]. They also mentioned that verapamil
folds both of its aromatic ring and insert itself in the hydrophobic region of lipid membranes
while leaving the charged part of the molecule close to lipid-water interface [69]. Such a picture
may be relevant to unbiased partitioning in phase coexisting lipid bilayers.
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Figure 29: Above shows temperature ramping of fluorescent GUVs of (3:2) DOPC:ESM +32%
Chol+4% verapamil; (A) 27°C; (B) 31.3°C-critical-like fluctuations and (C) >33.7°C-one Ld phase.

Figure 30: Above shows fluorescent GUV (3:2) DOPC:ESM+32% Chol critical-like fluctuations at
various verapamil concentrations: (A) 4% (31.3°C) and (B) 8% (31.4°C). For 2% verapamil, due to
the lack of critical-like fluctuations image, Tm (@31.3°C) was taken as the average of two
temperatures, one from homogenous Ld phase GUVs and one from phase-separated GUVs

Table 3: Summary of Tm of various verapamil % in 3:2 DOPC/ESM + 32%chol GUVs. Tm does not
change as verapamil % increases.
3:2 DOPC/ESM + 32%chol + verapamil %
2
4
8

Tm
31.3°C
31.3°C
31.4°C

54

CHAPTER SEVEN:
CONCLUSION

This thesis work probes various peptide/drug molecules interacting with lipid model
membranes, causing Tm change, vesicle budding, and membrane disruption. With the intention
to study these physical phenomena, ternary lipid model GUVs of (3:2) DOPC:ESM+32% Chol was
adopted in majority parts of this thesis. The use of fluorescent microscopy and
electroformation method are also vital to the study of this thesis. The main conclusions of each
studies are summarized as follows:


The increase presence of ESM and Chol in GUVs produces larger Lo domains for
temperature below Tm; GUV’s Tm is also modified as ESM and Chol increase.



M2TM peptide in GUVs increase Tm; vesicle buddings is more prevalent when M2TM is
added after GUVs are electroformed compared to electroformed M2TMincorporateded GUVs; vesicle budding is caused by negative curvature induced by
M2TM insertion into lipid membranes.



Addition of polyQ (>35Q) aggregates to homogenous and phase-separated GUVs
resulted in membrane rupture.



Tamoxifen in GUVs increases Tm; genistein in GUVs increases Tm about 2ᵒC (33.1ᵒC)
from pure ternary lipid model GUVs (Tm = 31.7ᵒC); verapamil in GUVs has no effect on
Tm .
55

With this, ends the journey of exploring a small piece of science on lipid membranes. The hope
of this thesis work is to provide supporting information to any research that helps in
therapeutic strategies, for the betterment of life.
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APPENDIX A
Electroformation Procedure
Materials: 200mM Sucrose solution, 200mM Glucose solution, 0.48 mg/ml DPPE-rhodamine in
chloroform, 2mg/ml DOPC in chloroform, 2mg/ml ESM in chloroform, 2mg/ml Chol in
chloroform, propanol, ITO (Indium Tin Oxide) slides, O-rings, paper clips, conductor-coated
alligator clips wire, syringes, vacuum pump, pastuer pipet, VWR heating system with aluminum
block

Preparation:
1) Clean ITO slides and O-ring with propanol. After dried, wipe ITO slides (both sides)
and Pastuer pipette with lens paper. Set aside.
2) Clean syringes with chloroform. Set aside.
3) Warm up sucrose, glucose, dye, lipid to room temperature. Set aside.
4) Heat and stabilize cleaned ITO slides, O-ring, Pasteur pipette, and aluminum block to
about 55°C. We use hot plate.

Method:
1) Syringe 50µl of 2mg/ml DOPC, 30µl of 2mg/ml ESM, 19µl of 2mg/ml Chol, 2µl of
0.48mg/ml DPPE-rhodamine, and 99µl of chloroform into a glass test tube.
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2) Vortex solution by Fisher fixed speed vortex mixer for 1 minute.
3) Syringe 50µl of mixed solution onto conductive side and top part of an ITO slide.
REMEMBER: ITO slides should be about 55°C (refer Preparation step 4).
4) Gently roll solution over the top half on ITO slide until a thin layer of lipid was
formed using the curved body of Pasteur pipette. Another 50µl of mixed solution
syringe onto the same spot on the same ITO slide. “Roll” action performed to get a
thin layer of lipid.
5) Repeat Method step 3 and 4 for other ITO slides. 4 slides corresponded to 2 samples
in aluminum block.
6) Vacuum ITO slides for about 45-60 minutes using vacuum pump.
7) Heat ITO slides back to about 55°C.
8) Place O-ring on top of the lipid film formed on the ITO slide. Place another ITO slide
with film layer touching the O-ring, like a sandwich. Press the “O-ring-ITO sandwich”
firmly without causing O-ring to move to ensure O-ring sticks to one of the ITO
slides. Slowly peel off one ITO slide, O-ring will stick to one of the ITO slide.
9) Once O-ring joined with one ITO slide, place identical O-ring at the bottom half of
the joined ITO slide. Then pipet 500µl of 0.2M Sucrose into the O-ring with lipid film,
and immediately but carefully cover with another ITO slide like the sandwich in
Method step 8.
10) Clip the “sandwich” at the bottom half of ITO slides-O-ring sandwich using paper
clip.
11) Soak the leakage away with Kim wipes if there are leakage.
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12) Slide the sandwich into one of the slot in the aluminum block.
13) Hook alligator clip wires from a function generator to the slides.
14) Set function generator parameter to use sine wave, 2Vpp and 10Hz.These
parameters can be changed to experiment on the size of GUVs. Apply voltage for 2
hours under these setting when aluminum block hits 60°C. Shut off function
generator after 2 hours. Allow aluminum block to cool down gradually from 60 to
22°C over the span of 10 hours. Temperature is controlled by Digi-Sense
temperature controller.

Harvesting:
1) Remove alligator clips from ITO slides and unclip the O-ring-ITO sandwich.
2) Carefully pry open one side of ITO slide and then pipet out the GUV solution in the
O-ring into 2ml of 200mM Glucose. Gently homogenize the GUV solution in glucose.
3) Clean ITO slides and O-rings with propanol and store in pure water.
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APPENDIX B
Programming Digi-Sense Temperature Controller

To program Digi-Sense temperature controller:
i)

Turn power on, and you will see 2 rows of number. The red number
represent current temperature the probe is reading. The yellow number
below it represent set/desired temperature.

ii)

To change desired temperature to a different value, simply press the “up
arrow” or “down arrow” button. The “infinity” button acts like an exit
button. The “green” button brings you to the menu. I never use the “EZ”
button.

iii)

Press and hold “green” button for 3 seconds and you will see the screen
below:

There are 4 programmable programs, denoted by P1 through P4. To see
them, use “up/down arrow”. NOTE: P1 is already programmed for GUV
synthesis from 60-22 °C. So select P2 or others to start programming.
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iv)

To select P2, press the “green” button. The scree will display

Number 11 is basically step 1 for profile 2. This number 11 will go up to
20, which allow 10 steps for programming. If you choose P3, you will see
21 which corresponding to step 1 of profile 3.
v)

At number 11, press “green” button once. You will see

t1 represent time. You can press “up/down arrow” to look at other type
of heating mode. At t1 screen, press “green” button. This allows you to
set your desired temperature and duration of heating.
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You set by using “up/down arrow” then confirm it by pressing the
“green” button once.
vi)

After this, the screen below will appear

Make sure Ent 1 and 2 are both “off”. Use “up/down arrow”.
You will then be directed to this page again. Up to this point, you have
successfully program temperature and duration of heating in step 1.

vii)

Press “infinity” button to exit previous screen and go back to

Now use 12 to program step 2.
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Repeat procedure (v) to (vii) for subsequent steps. Once you have
programmed

all the steps, press “infinity” button few times until you get

to the home screen

with 2 numbers

To start the programmed program:
i)

Turn power on.

ii)

Press “green” button until you see screen below. You might see 11 instead of 1,
use “up/down arrow” to adjust.
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This is step 1 in profile 1. To get to step 1 in profile 2, use “up/down arrow”
button to go

to 11.

Then press “green” button to get to the screen below

Use “up/down arrow” button to change the screen to “step” as below

Then click the “green” button. This runs the program. And you will see this
screen
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The number below changes because it is ramping up to set value. The
“mountain” icon to the right of the bottom number shows that the program is
running.
iii)

To end the profile, press “green” button until you see screen below

, if you are running profile 1

, if you are running profile 2
Press “green” button and you will see screen below
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Use “up/down arrow” button to get to “End” like screen below

Press “green” button and this will end the temperature ramping.

75

APPENDIX C
Publications


Chian Sing Ho, Nawal K. Khadka, Fengyu She, Jianfeng Cai, and Jianjun Pan*. Influenza
M2 Transmembrane Domain Senses Membrane Heterogeneity and Enhances
Membrane Curvature. Langmuir 2016, DOI: 10.1021/acs.langmuir.6b00150.



Chian Sing Ho, Nawal K. Khadka, Fengyu She, Jianfeng Cai, and Jianjun
Pan*. Polyglutamine Aggregates Impair Lipid Membrane Integrity and Enhance Lipid
Membrane Rigidity. Biochimica et Biophysica Acta - Biomembranes 2016, 1858: 661670.



Chian Sing Ho, Nawal K. Khadka, and Jianjun Pan*. Sub-Ten-Nanometer Heterogeneity
of Solid Supported Lipid Membranes Determined by Solution Atomic Force
Microscopy. Biochimica et Biophysica Acta - Biomembranes 2016, 1858: 181-188.



Nawal K. Khadka,Chian Sing Ho, and Jianjun Pan*. Macroscopic and Nanoscopic
Heterogeneous Structures in a Three-Component Lipid Bilayer Mixtures Determined by
Atomic Force Microscopy. Langmuir 2015, 31: 12417-12425.



Nawal K. Khadka, Xiaolin Cheng, Chian Sing Ho, John Katsaras, and Jianjun Pan*.
Interactions of the Anticancer Drug Tamoxifen with Lipid Membranes. Biophysical
Journal 2015, 108: 2492-2501.



Jianjun Pan, Xiaolin Cheng, Melissa Sharp, Chian Sing Ho, Nawal Khadka, John Katsaras.
Structural and Mechanical Properties of Cardiolipin Lipid Bilayers Determined Using
76

Neutron Spin Echo, Small Angle Neutron and X-ray Scattering, and Molecular Dynamics
Simulations. Soft Matter 2014, 11:130-138.

77

